| Management target | Net Profit FY27 |
|---|
| Margins | Consolidated EBITDA margin improved 53 bps to 15.0%. |
|---|---|
| Demand visibility | Strong pipeline for specialty chemicals and premium spirits. |
Growth
Net revenue reached ₹1,130 Cr (+9% YoY), EBITDA rose to ₹170 Cr (+13%), and PAT increased to ₹97 Cr.
Outlook
NCLT-approved demerger to create focused entities; targeting ₹1,000 Cr Spirits EBITDA in 4-5 years and debt-free status by FY28.
Risks
Rising crude prices impacting competitiveness and raw material availability for bio-pharma segments.
Last quarter's promises, checked
Delivered
- Targeted NCLT demerger order by June 2026 → Delivered order on 17 July 2026 (= BEAT)
- Guided debt reduction via prepayments → Delivered ₹804 Cr prepaid in Q4FY26 (= BEAT)
- Planned 'Jamun Flavour' launch → Delivered launch in current quarter (= BEAT)
Partly delivered
- Guided Chemicals growth via higher value-added portfolio → Delivered +20.6% revenue but margins remain sensitive to crude (= PARTIAL)
Investor Presentation filed with BSE, NSE: INDIAGLYCO. Summary written with AI assistance from the document.
India Glycols Ltd: key numbers
- Share price
- ₹309.90
- Market cap
- ₹2,077 Cr
- Revenue (annual)
- ₹4,211 Cr
- Net profit (annual)
- ₹292.8 Cr
- P/E (TTM)
- 6.6×Sector 37.5×
- Promoter holding
- 59.63%+0.00% QoQ
- FII holding
- 2.24%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from India Glycols Ltd
All →India Glycols Board Meeting Outcome
India Glycols Limited announced that its subsidiary, IGL Spirits Limited, approved share allotment under a Scheme of Arrangement and appointed new key managerial personnel.
India Glycols Earnings Call Transcript: Key Takeaways
India Glycols posted a record Q1 with 19% net revenue growth and 32% PAT growth, driven by its Bio-Pharma segment. Management is aggressively pivoting toward a premium-led consumer model through restructuring and new liquor brand partnerships.
India Glycols Q1 FY27 Results: Net Profit ₹96.8 Cr, Up 32.2% YoY
India Glycols Ltd reported revenue from operations of ₹2,988 Cr (+19.4% YoY) and net profit of ₹96.8 Cr (+32.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹96.8 Cr · +32.2% YoY
India Glycols Earnings Call: Key Takeaways
India Glycols reported a strong FY26 with net revenue of ₹4,211cr (up 11.8%) and PAT of ₹293cr (up 26.8%). Strategy focuses on premiumization in spirits and expanding bio-based chemicals.
India Glycols Earnings Call: Key Takeaways
India Glycols delivered solid FY26 performance led by portable spirits and biofuels, successfully deleveraging the balance sheet through promoter equity infusion and internal accruals while shifting toward a premium-led liquor portfolio.
India Glycols Earnings Call: Key Takeaways
India Glycols delivered strong FY26 performance with 11.8% Net Revenue growth and 26.8% PAT growth. Management is executing a three-way demerger into Chemicals, Spirits/Bio-Fuel, and Bio-Pharma entities.